phase 3
trial 1
carfilzomib 1
pr 1
combination 2
vorinostat 1
saha 1
patients 1
relapsed 2
refractory 2
bcell 2
lymphomas 1
study 2
imexon 1
prooxidant 1
molecule 1
nonhodgkin 1
lymphoma 1
ii 1
gemcitabine 1
oxaliplatin 1
panitumumab 1
kras 1
wildtype 1
unresectable 1
metastatic 1
biliary 1
tract 1
gallbladder 1
cancer 1
